Some studies have shown that antiplatelets agents could reduce organ dysfunction in septic shock in mice and human models. Platelets are actors in immunity and their activation can be complicated by tissue damage with vascular occlusions which can lead to organ dysfunction. Investigators can hypothesize an increase in platelet activation and in leukocyte-platelet aggregates in septic shock.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
27
Specific platelet activation markers, circulating leukocyte-platelet aggregates will be assessed in peripheral venous blood at the admission in intensive care unit and 48 hours later for leukocyte-platelet aggregates measurements.
Specific platelet activation markers, circulating leukocyte-platelet aggregates will be assessed in peripheral venous blood during the orthopedic surgical anesthesia consultation.
CHU Toulouse
Toulouse, France
Level of platelets activation markers expression (CD62-P, antibody CD63, CD42b)
Specific platelet activation markers and circulating leukocyte-platelet aggregates will be assessed in peripheral venous blood at the admission in intensive care unit for patients in test group and during the orthopedic surgical anesthesia consultation for patients in control group.
Time frame: T0 at the admission in intensive care unit
Level of platelets activation markers expression (CD62-P, CD63, CD42b)
Specific platelet activation markers and circulating leukocyte-platelet aggregates will be assessed in peripheral venous blood 48 hours later admission in intensive care unit only for patients in test group.
Time frame: T48 hours after admission in intensive care unit
Rate of leukocyte-platelet aggregates
Time frame: T0 at the admission in intensive care unit
Kinetics of leukocyte-platelet aggregates formation
Time frame: T0 at the admission in intensive care unit
Correlation of leukocyte-platelet aggregates rate and septic shock severity.
Time frame: T0 at the admission in intensive care unit
Comparison of platelet activation in subjects treated or not with antiplatelet agents.
Time frame: T0 at the admission in intensive care unit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.